Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v4-EN
Language English English
Date Updated 2018-09-25 2017-03-21
Drug Identification Number 00001686 00001686
Brand name XYLOCAINE VISCOUS 2% XYLOCAINE VISCOUS 2%
Common or Proper name lidocaine hydrochloride solution lidocaine hydrochloride solution
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients LIDOCAINE HYDROCHLORIDE LIDOCAINE HYDROCHLORIDE
Strength(s) 20MG 20MG
Dosage form(s) LIQUID LIQUID
Route of administration ORAL TOPICAL ORAL TOPICAL
Packaging size 1x100mL 1x100mL
ATC code N01BB N01BB
ATC description ANESTHETICS, LOCAL ANESTHETICS, LOCAL
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date 2016-07-07 2016-07-07
Actual start date 2016-07-07 2016-07-07
Estimated end date Unknown
Actual end date 2018-09-24
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments AstraZeneca Canada Inc. has transferred the marketing authorization to Aspen Pharmacare Canada Inc. as of July 12, 2018. The drug shortage for Xylocaine Viscous will be posted by Aspen Pharmacare Canada Inc.
Health Canada comments